After a promising feasibility study showing the potential of its natural language processing models, MSK has ambitions to use them in patient care.

The New York-based startup is focused on using AI to accurately predict not only if a patient has cancer, but also what their ...

Ataraxis AI, the leading AI precision medicine company, today announced its $20.4 million Series A financing led by AIX ...

One of its biggest competitors is Together AI, which also looks to help companies “turbocharge” their model building work, ...

Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.

NASHUA, N.H. and TORONTO, March 05, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered cancer ...

The AI model processes pre-contrast and a single post-contrast T1 image, identifying suspicious regions and assigning a ...

Health tech company Cera's artificial intelligence app can also predict the onset of winter viruses, and is being keenly ...

First Ascent Biomedical, a Miami biotech company and cancer researcher, will receive $2 million in funding from the Florida ...

Megan Shellhorn, local mom, breast cancer survivor founds Pink Lights the Way to help patients find support DOGE ...

As part of the Summer Research Symposium, a panel of School of Medicine faculty members select outstanding posters for ...